Search

Home > GRACEcast Lung Cancer Video > Are There Distinctions Among Currently Available Oral EGFR Inhibitors for EGFR Mutation-Positive NSCLC?
Podcast: GRACEcast Lung Cancer Video
Episode:

Are There Distinctions Among Currently Available Oral EGFR Inhibitors for EGFR Mutation-Positive NSCLC?
Category: Science & Medicine
Duration: 00:02:22
Publish Date: 2015-10-20 14:00:00
Description:

Dr. Greg Riely, medical oncologist from MSKCC, considers the evidence on whether there are clinically significant differences among the currently available first and second generation oral EGFR inhibitors for patients with an EGFR mutation.
Total Play: 0